- Zacks•2 months ago
Achillion Pharmaceuticals, Inc. (ACHN) announced that it has received a milestone payment of $15 million from Johnson & Johnson's (JNJ) pharma wing, Janssen for the initiation of patient enrollment in the OMEGA-1 phase IIb global study of JNJ-4178.
- TheStreet.com•2 months ago
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
- Motley Fool•2 months ago
Achillion's foray outside of hepatitis C hits a snag.
ADA.F: Summary for ACHILLION PHARMACEUTICALS - Yahoo Finance
Achillion Pharmaceuticals, Inc. (ADA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 2:25PM CET
|Bid||3.95 x 43600|
|Ask||4.03 x 42000|
|Day's range||3.93 - 3.93|
|52-week range||3.66 - 8.24|
|PE ratio (TTM)||-13.28|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|